ISDA: 3FRG

Deposition Date 2009-01-08

Release Date 2010-01-12

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3FRG

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.70 Å

R-Value Free:

0.24

R-Value Work:

0.20

R-Value Observed:

0.21

Space Group:

I 21 21 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:cAMP-specific 3',5'-cyclic phosphodiesterase 4B
Gene (Uniprot):PDE4B
Mutagens:S482A, S487A, S489A
Chain IDs:A
Chain Length:353
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q07343 Pfam ID:PF00233 EC:3.1.4.53

Ligand Molecules

ARS

GOL

SK4

Primary Citation

Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration.

Lunniss, C.J, Cooper, A.W, Eldred, C.D, Kranz, M, Lindvall, M, Lucas, F.S, Neu, M, Preston, A.G, Ranshaw, L.E, Redgrave, A.J, Ed Robinson, J, Shipley, T.J, Solanke, Y.E, Somers, D.O, Wiseman, J.O.Show

Bioorg.Med.Chem.Lett. 19 1380 1385 (2009)

PMID: 19195882 DOI: 10.1016/j.bmcl.2009.01.045

Abstact

Crystallography-driven optimisation of a lead derived from similarity searching of the GSK compound collection resulted in the discovery of a series of quinoline derivatives that were highly potent and selective inhibitors of PDE4 with a good pharmacokinetic profile in the rat. Quinolines 43 and 48 have potential as oral medicines for the treatment of COPD.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form